Fig. 4

Quantification of anti-HCV triple-drug combinations against genotype 1b and 2a: Log–log plots of dose-response curves for 8 (a) and 6 (b) triple-drug combinations against HCV genotype 1b (a) and 2a (b). Each point represents the mean of five experiments for genotype 1b and four experiments for genotype 2a. For comparison of drugs, concentration of each drug was based on a consistent ratio of its IC₅₀ value. (c) and (d) show RCI₉₅ rankings of the triple-drug combinations against HCV genotype 1b and 2a, respectively